Skip to content

Study · Not a test of the peptide alone · 1993

4 results

Synthesis of a tritiated human growth hormone releasing peptide.

Shu AY, Heys JR

International journal of peptide and protein research1 Nov 1993Cited by 1 (Europe PMC)

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study4

No result from this study comes from a test of the peptide.

Studies that did not test the peptide alone4

In this study, GHRP-6 was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking GHRP-6.

  1. 01LabNot a test of GHRP-6 aloneIn vitro (cell-free)Other

    In cell-free synthesis, tritium-halogen exchange produced tritium-labeled GH-releasing peptide.

    In plain wordsIn lab tests, tritium-halogen exchange produced labeled GH-releasing peptide.

    Peptide
    GHRP-6
    Outcome
    Not applicableRadiolabeled peptide synthesis
    Study

    n: not reported in source

    Outcome group
    Receptor activity and mechanism · Pharmacology

    Source sentences

    Summary
    Tritium-labeled growth hormone releasing peptide His-D-Trp-Ala-Trp-D-Phe-Lys-NH2 was synthesized by tritium-halogen exchange on the precursor His-5,7-Br2-D-Trp-Ala-Trp-D-Phe-Lys-NH2.

    In this study, GHRP-6 was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking GHRP-6.

  2. 02LabNot a test of GHRP-6 aloneIn vitro (cell-free)Other

    The radiolabeled GH-releasing peptide preparation had a specific activity of 29 Ci/mmol.

    In plain wordsIn lab tests, labeled GH-releasing peptide had a specific activity of 29 Ci/mmol.

    Peptide
    GHRP-6
    Outcome
    Not applicableSpecific activity
    Study

    n: not reported in source

    Outcome group
    Receptor activity and mechanism · Pharmacology

    Measurements

    Specific activity
    29 Ci/mmol
    radiolabeled peptide

    Source sentences

    Summary
    The radiolabeled peptide had a specific activity of 29 Ci/mmol and a radiochemical purity of 95%.

    In this study, GHRP-6 was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking GHRP-6.

  3. 03LabNot a test of GHRP-6 aloneIn vitro (cell-free)Other

    The radiolabeled GH-releasing peptide preparation had radiochemical purity of 95%.

    In plain wordsIn lab tests, labeled GH-releasing peptide had radiochemical purity of 95%.

    Peptide
    GHRP-6
    Outcome
    Not applicableRadiochemical purity
    Study

    n: not reported in source

    Outcome group
    Receptor activity and mechanism · Pharmacology

    Measurements

    Radiochemical purity
    95%
    radiolabeled peptide

    Source sentences

    Summary
    The radiolabeled peptide had a specific activity of 29 Ci/mmol and a radiochemical purity of 95%.

    In this study, GHRP-6 was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking GHRP-6.

  4. 04LabNot a test of GHRP-6 aloneIn vitro (cell-free)Other

    NMR localized most GH-releasing peptide tritium label to the expected indole positions in D-Trp.

    In plain wordsIn lab tests, most of the GH-releasing peptide tritium label occupied the expected positions in D-Trp.

    Peptide
    GHRP-6
    Outcome
    Not applicableTritium label location
    Study

    n: not reported in source

    Outcome group
    Receptor activity and mechanism · Pharmacology

    Source sentences

    Summary
    The tritium label was shown by 3H NMR to be located mostly at the expected 5,7-positions of the indole nucleus in the D-Trp residue.

    In this study, GHRP-6 was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking GHRP-6.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    21 Oct 2026, 15:58 UTC

    Study results updated

  2. Version 1

    9 Oct 2026, 03:13 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.